Myeloid cells, BAFF, and IFN-γ establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice

Journal of Experimental Medicine

Volumn 207, Issue 8, 2010, Pages 1757-1773

  Scapini, Patrizia ^a   Hu, Yongmei ^a   Chu, Ching Liang ^b   Migone, Thi Sau ^c   DeFranco, Anthony L ^a   Cassatella, Marco A ^d   Lowell, Clifford A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; GAMMA INTERFERON; MONOCLONAL ANTIBODY; AUTOANTIBODY; B CELL ACTIVATING FACTOR RECEPTOR; HCK PROTEIN, MOUSE; HEMATOPOIETIC CELL KINASE; LYN PROTEIN-TYROSINE KINASE; ONCOPROTEIN; PROTEIN TYROSINE KINASE; PROTO-ONCOGENE PROTEINS C-FGR; TNFRSF13C PROTEIN, MOUSE; TNFSF13B PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BONE MARROW CELL; CELL ACTIVATION; CELL INFILTRATION; CELL PROLIFERATION; DISEASE COURSE; GENE; GENE DELETION; INFLAMMATION; INNATE IMMUNITY; LEUKOCYTE; LYN GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; B LYMPHOCYTE; BIOLOGICAL MODEL; BLOOD; C57BL MOUSE; CYTOLOGY; DENDRITIC CELL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; MACROPHAGE; METABOLISM; NEPHRITIS; PATHOLOGY; SPLEEN; SPLENOMEGALY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOIMMUNITY; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; GENE EXPRESSION; INFLAMMATION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; MYELOID CELLS; NEPHRITIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; SPLEEN; SPLENOMEGALY; SRC-FAMILY KINASES; T-LYMPHOCYTES;

EID: 77955343903     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20100086     Document Type: Article

References (59)

1. Bagavant, H., and S.M. Fu. 2005. New insights from murine lupus: disassociation of autoimmunity and end organ damage and the role of T cells. Curr. Opin. Rheumatol. 17:523-528. doi:10.1097/01.bor.0000169361.23325.1e
2. Balomenos, D., R. Rumold, and A.N. Theofilopoulos. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101:364-371. doi:10.1172/JCI750 (Pubitemid 28067333)
3. Berton, G., A. Mócsai, and C.A. Lowell. 2005. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol. 26:208-214. doi:10.1016/j.it.2005.02.002 (Pubitemid 41556858)
4. Cash, H., M. Relle, J. Menke, C. Brochhausen, S.A. Jones, N. Topley, P.R. Galle, and A. Schwarting. 2010. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J. Rheumatol. 37:60-70. doi:10.3899/jrheum.090194
5. Chan, V.W., F. Meng, P. Soriano, A.L. DeFranco, and C.A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity. 7:69-81. doi:10.1016/S1074-7613(00)80511-7
6. Chan, V.W., C.A. Lowell, and A.L. DeFranco. 1998. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes. Curr. Biol. 8:545-553. doi:10.1016/S0960-9822(98)70223-4 (Pubitemid 28222888)
7. Chan, O.T., L.G. Hannum, A.M. Haberman, M.P. Madaio, and M.J. Shlomchik. 1999. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189:1639-1648. doi:10.1084/jem.189.10.1639
8. Chu, C.L., and C.A. Lowell. 2005. The Lyn tyrosine kinase differentially regulates dendritic cell generation and maturation. J. Immunol. 175:2880-2889.
9. Cohen, P.L., R. Caricchio, V. Abraham, T.D. Camenisch, J.C. Jennette, R.A. Roubey, H.S. Earp, G. Matsushima, and E.A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196:135-140. doi:10.1084/jem.20012094
10. Ding, C. 2008. Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases. Expert Opin. Biol. Ther. 8:1805-1814. doi:10.1517/14712598.8.11.1805
11. Dörner, T., A. Radbruch, and G.R. Burmester. 2009. B-cell-directed therapies for autoimmune disease. Nat. Rev. Rheumatol. 5:433-441. doi:10.1038/nrrheum.2009.141
12. Ettinger, R., G.P. Sims, R. Robbins, D. Withers, R.T. Fischer, A.C. Grammer, S. Kuchen, and P.E. Lipsky. 2007. IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 178:2872-2882.
13. Gross, A.J., J.R. Lyandres, A.K. Panigrahi, E.T. Prak, and A.L. DeFranco. 2009. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance. J. Immunol. 182:5382-5392. doi:10.4049/jimmunol. 0803941
14. Hamilton, J.A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8:533-544. doi:10.1038/nri2356
15. Hanada, T., H. Yoshida, S. Kato, K. Tanaka, K. Masutani, J. Tsukada, Y. Nomura, H. Mimata, M. Kubo, and A. Yoshimura. 2003. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity. 19:437-450. doi:10.1016/S1074-7613(03)00240-1
16. Harder, K.W., L.M. Parsons, J. Armes, N. Evans, N. Kountouri, R. Clark, C. Quilici, D. Grail, G.S. Hodgson, A.R. Dunn, and M.L. Hibbs. 2001. Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity. 15:603-615. doi:10.1016/S1074-7613(01)00208-4
17. Harder, K.W., C. Quilici, E. Naik, M. Inglese, N. Kountouri, A. Turner, K. Zlatic, D.M. Tarlinton, and M.L. Hibbs. 2004. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood. 104:3901-3910. doi:10.1182/blood-2003-12- 4396
18. Harigai, M., M. Kawamoto, M. Hara, T. Kubota, N. Kamatani, and N. Miyasaka. 2008. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B. J. Immunol. 181:2211-2219.
19. Hibbs, M.L., D.M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S.A. Stacker, and A.R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 83:301-311. doi:10.1016/0092-8674(95)90171-X
20. Huard, B., P. Schneider, D. Mauri, J. Tschopp, and L.E. French. 2001. T cell costimulation by the TNF ligand BAFF. J. Immunol. 167:6225-6231.
21. Kalled, S.L. 2005. The role of BAFF in immune function and implications for autoimmunity. Immunol. Rev. 204:43-54. doi:10.1111/j.0105-2896.2005.00219.x (Pubitemid 40460492)
22. Kaneko, Y., F. Nimmerjahn, M.P. Madaio, and J.V. Ravetch. 2006. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 203:789-797. doi: 10.1084/jem.20051900
23. Lai Kwan Lam, Q., O. King Hung Ko, B.J. Zheng, and L. Lu. 2008. Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc. Natl. Acad. Sci. USA. 105:14993-14998. doi:10.1073/pnas. 0806044105
24. Lesley, R., Y. Xu, S.L. Kalled, D.M. Hess, S.R. Schwab, H.B. Shu, and J.G. Cyster. 2004. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 20:441-453. doi:10.1016/S1074-7613(04) 00079-2
25. Liang, B., D.B. Gardner, D.E. Griswold, P.J. Bugelski, and X.Y. Song. 2006. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus. Immunology. 119:296-305. doi:10.1111/j.1365-2567.2006.02433.x
26. Lowell, C.A. 2004. Src-family kinases: rheostats of immune cell signaling. Mol. Immunol. 41:631-643. doi:10.1016/j.molimm.2004.04.010 (Pubitemid 38824619)
27. Mackay, F., and H. Leung. 2006. The role of the BAFF/APRIL system on T cell function. Semin. Immunol. 18:284-289. doi:10.1016/j.smim.2006.04.005
28. Mackay, F., and P. Schneider. 2009. Cracking the BAFF code. Nat. Rev. Immunol. 9:491-502. doi:10.1038/nri2572
29. Mackay, F., P.A. Silveira, and R. Brink. 2007. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 19:327-336. doi:10.1016/j.coi.2007.04.008
30. Maeda, K., A. Malykhin, B.N. Teague-Weber, X.H. Sun, A.D. Farris, and K.M. Coggeshall. 2009. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood. 113:4534-4540. doi:10.1182/blood-2008-12-192559
31. Meng, F., and C.A. Lowell. 1997. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J. Exp. Med. 185:1661-1670. doi:10.1084/jem.185.9. 1661
32. Mócsai, A., C.L. Abram, Z. Jakus, Y. Hu, L.L. Lanier, and C.A. Lowell. 2006. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7:1326-1333. doi:10.1038/ni1407
33. Moisini, I., and A. Davidson. 2009. BAFF: a local and systemic target in autoimmune diseases. Clin. Exp. Immunol. 158:155-163. doi:10.1111/j.1365-2249. 2009.04007.x
34. Ng, L.G., A.P. Sutherland, R. Newton, F. Qian, T.G. Cachero, M.L. Scott, J.S. Thompson, J. Wheway, T. Chtanova, J. Groom, et al. 2004. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173:807-817.
35. Ng, L.G., C.R. Mackay, and F. Mackay. 2005. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42:763-772. doi:10.1016/j.molimm.2004.06.041 (Pubitemid 40489025)
36. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 3:549-560. doi:10.1016/1074-7613(95)90126-4
37. Pereira, S., and C. Lowell. 2003. The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J. Immunol. 171:1319-1327.
38. Rahman, A., and D.A. Isenberg. 2008. Systemic lupus erythematosus. N. Engl. J. Med. 358:929-939. doi:10.1056/NEJMra071297
39. Ramanujam, M., and A. Davidson. 2008. BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? Immunol. Rev. 223:156-174. doi:10.1111/j.1600-065X.2008.00625.x
40. Ramanujam, M., X. Wang, W. Huang, Z. Liu, L. Schiffer, H. Tao, D. Frank, J. Rice, B. Diamond, K.O. Yu, et al. 2006. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J. Clin. Invest. 116:724-734. doi:10.1172/JCI26385
41. Rane, S.G., and E.P. Reddy. 2002. JAKs, STATs and Src kinases in hematopoiesis. Oncogene. 21:3334-3358. doi:10.1038/sj.onc.1205398
42. Sarantopoulos, S., K.E. Stevenson, H.T. Kim, N.S. Bhuiya, C.S. Cutler, R.J. Soiffer, J.H. Antin, and J. Ritz. 2007. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clin. Cancer Res. 13:6107-6114. doi:10.1158/1078-0432.CCR-07-1290
43. Scapini, P., F. Bazzoni, and M.A. Cassatella. 2008. Regulation of B-cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. Immunol. Lett. 116:1-6.
44. Scapini, P., S. Pereira, H. Zhang, and C.A. Lowell. 2009. Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol. Rev. 228:23-40. doi:10.1111/j.1600-065X.2008.00758.x
45. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17:282-289. doi:10.1016/j.coi.2005.04.005 (Pubitemid 40692663)
46. Scholz, J.L., J.E. Crowley, M.M. Tomayko, N. Steinel, P.J. O'Neill, W.J. Quinn III, R. Goenka, J.P. Miller, Y.H. Cho, V. Long, et al. 2008. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc. Natl. Acad. Sci. USA. 105:15517-15522. doi:10.1073/pnas.0807841105
47. Shlomchik, M.J., J.E. Craft, and M.J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1:147-153. doi:10.1038/35100573
48. Silver, K.L., T.L. Crockford, T. Bouriez-Jones, S. Milling, T. Lambe, and R.J. Cornall. 2007. MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur. J. Immunol. 37:2734-2743. doi:10.1002/eji.200737293
49. Stadanlick, J.E., and M.P. Cancro. 2008. BAFF and the plasticity of peripheral B cell tolerance. Curr. Opin. Immunol. 20:158-161. doi:10.1016/j.coi.2008.03.015
50. Stohl, W., D. Xu, K.S. Kim, M.N. Koss, T.N. Jorgensen, B. Deocharan, T.E. Metzger, S.A. Bixler, Y.S. Hong, C.M. Ambrose, et al. 2005. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum. 52:2080-2091. doi:10.1002/art.21138
51. Stranges, P.B., J. Watson, C.J. Cooper, C.M. Choisy-Rossi, A.C. Stonebraker, R.A. Beighton, H. Hartig, J.P. Sundberg, S. Servick, G. Kaufmann, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity. 26:629-641. doi:10.1016/j.immuni.2007.03.016
52. Sutherland, A.P., L.G. Ng, C.A. Fletcher, B. Shum, R.A. Newton, S.T. Grey, M.S. Rolph, F. Mackay, and C.R. Mackay. 2005. BAFF augments certain Th1-associated inflammatory responses. J. Immunol. 174:5537-5544.
53. Theofilopoulos, A.N., S. Koundouris, D.H. Kono, and B.R. Lawson. 2001. The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res. 3:136-141. doi:10.1186/ar290
54. Tsantikos, E., S.A. Oracki, C. Quilici, G.P. Anderson, D.M. Tarlinton, and M.L. Hibbs. 2009. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J. Immunol. 184:1348-1360.
55. Xu, Y., K.W. Harder, N.D. Huntington, M.L. Hibbs, and D.M. Tarlinton. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity. 22:9-18.
56. Yanaba, K., J.D. Bouaziz, T. Matsushita, C.M. Magro, E.W. St.Clair, and T.F. Tedder. 2008. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223:284-299. doi:10.1111/j.1600-065X.2008.00646.x
57. Ye, Q., L. Wang, A.D. Wells, R. Tao, R. Han, A. Davidson, M.L. Scott, and W.W. Hancock. 2004. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur. J. Immunol. 34:2750-2759. doi:10.1002/eji.200425198
58. Yu, C.C., T.S. Yen, C.A. Lowell, and A.L. DeFranco. 2001. Lupuslike kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr. Biol. 11:34-38. doi:10.1016/S0960-9822(00)00024-5
59. Zhu, J., X. Liu, C. Xie, M. Yan, Y. Yu, E.S. Sobel, E.K. Wakeland, and C. Mohan. 2005. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J. Clin. Invest. 115:1869-1878. doi:10.1172/JCI23049